Position in GNLX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$28,531
+$5,592 QoQ
Shares Held
9,479
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 72 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blue Trust, Inc. holds $5,572,579 across 69 Biotechnology names. GNLX ranks #20 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
17,105 | $930,682 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,677 | $833,015 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
2,961 | $713,511 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
85,888 | $560,848 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
859 | $535,620 | |
| 6 | DMAC |
DiaMedica Therapeutics Inc.
|
69,122 | $486,618 | |
| 7 | GMAB |
Genmab A/S
|
11,676 | $320,739 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
805 | $229,400 |
All Filings in GNLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,531 | 9,479 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $22,939 | 9,479 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $41,328 | 9,479 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $42,718 | 10,171 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $29,190 | 10,171 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $27,461 | 10,171 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $24,003 | 10,171 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $23,472 | 9,904 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $19,312 | 9,904 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $63,682 | 9,904 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $226 | 9,237 | Shares | Sole | 2024-01-18 | |
| No filing history on record for this holder in this stock. | ||||||